| Primary information |
|---|
| ID | antitb_1732, |
| Name | US 2007/003721 |
| N-Terminal modification | Seq ID No 22 |
| C-Terminal Modification | YPHHFKHRHIPIGGGS |
| Chemical Modification | Free |
| Linear/Cyclic | Free |
| Length | None |
| Chirality | Linear |
| Nature | 16 |
| Source | L |
| Species | Synthetic |
| Strain | From random peptide libraries diplayed on bacteriophage M14 |
| Inhibition Concentration | Mycobacterium tuberculosis |
| In Vitro/ In vivo | Mycobacterium tuberculosis |
| Cell Line | 100 μM completely inhibits the cahpaeron activity of Hsp 16.3 |
| Inhibition Concentration | In vitro |
| Sequence | 2007 |
| Cytotoxicity | Mouse bone marrow derive dmacrophages and THP-1 |
| In vivo Model | NA |
| Lethal Dose | NA |
| Immune Responce | None |
| Mechanism of Action | NA |
| Target | NA |
| Combination Therapy | Inhibit chaperon activity of heat shock protein 16.3 (Hsp 16.3) |
| Other activities | Heat shock protein (Hsp 16.3) |
| PMID | None |
| Year of Publication | None |
Tertiary Structure
(Technique) | Not Predicted), |